Telemedicine prescribing has expanded access to GLP-1 medications but varies in quality and cost
They can help identify the cause and discuss whether adjusting your injection technique, trying semaglutide injection site reaction treatments, or switching to the Wegovy pill might be the right next step
Understanding the basic pharmacology explains why management strategies focus on gastric motility, meal composition, and dose titration

GLP-1 is a multifaceted hormone, and the use of its analogs is associated with broad metabolic effects: they increase insulin secretion, decrease glucagon release, increase glucose uptake in muscles, decrease glucose production in the liver, improve lipid profile, slow gastric emptying, and increase satiety leading to weight loss ( GLP-1RA have been used to treat T2D for ~20 years, and they have transformed T2D management in pediatric and adult populations ( 4.1 HbA1c reduction 4.1.1 Uncontrolled studies In a small, uncontrolled study, weekly semaglutide in 10 patients with newly diagnosed T1D, mean HbA1c improved dramatically from 11.7 2.1% to 5.7 0.4% at 12 months ( 4.1.2 RCTs Several blinded, placebo-controlled RCTs have demonstrated a significant reduction in HbA1c when adding GLP-1RA to either multiple daily injections (MDI) or continuous subcutaneous infusion of insulin (CSII), ranging between 0.1-0.7% (61) ( Table 1 )
Heres something you wont find on most telehealth landing pages
Svensson is the senior author of the research, which was published March 5 in Nature